Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clinical Outcomes
100%
Economic Outcomes
100%
Hyporesponsiveness
100%
Erythropoiesis-stimulating Agents
100%
Hypo-responders
45%
Normoresponder
36%
Healthcare Resource Utilization
27%
Cardiovascular Hospitalizations
18%
Dialysis
18%
Dialysis Patients
18%
Hyporesponsive
18%
Hospitalization Rate
18%
Hospitalization
9%
United States
9%
Clinical Significance
9%
Young Women
9%
High Mortality
9%
Medicare
9%
Baseline Characteristics
9%
Incidence Rate
9%
Retrospective Observational Study
9%
Exclusion Criteria
9%
Generalized Linear Model
9%
Skilled nursing Facility
9%
Analytical Approach
9%
United States Renal Data System (USRDS)
9%
Hypo
9%
1-year Mortality
9%
Iron Deficiency
9%
Categorical Variables
9%
Cardiovascular Events
9%
Wilcoxon Rank Sum Test
9%
Emergency Department Visits
9%
US Medicare
9%
Hospice
9%
Medicaid Patients
9%
Outcome Association
9%
Inpatient Stay
9%
Home Care Agencies
9%
Homestay
9%
Erythropoietin Resistance
9%
Dialysis Duration
9%
Erythropoiesis-stimulating Agent Resistance
9%
Healthcare Costs
9%
Nursing and Health Professions
Antianemic Agent
100%
Health Care
25%
Medicare
16%
Cardiovascular Mortality
16%
Cohort Analysis
8%
Nursing Home
8%
Emergency Ward
8%
Health Care Cost
8%
Rank Sum Test
8%
Iron Deficiency
8%
Erythropoietin
8%
Home Health Agency
8%
Cardiovascular System
8%